PMDA — authorised 2 July 2018
- Marketing authorisation holder: Astellas Pharma Inc
- Status: approved
🇯🇵 Dificid in Japan
PMDA authorised Dificid on 2 July 2018
Marketing authorisation
Dificid in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Immunology approved in Japan
Frequently asked questions
Is Dificid approved in Japan?
Yes. PMDA authorised it on 2 July 2018.
Who is the marketing authorisation holder for Dificid in Japan?
Astellas Pharma Inc holds the Japanese marketing authorisation.